Watch the Dynetic-35 in action to treat high-grade iliac artery stenoses.

Case courtesy of Dr. Michael Lichtenberg.

High radial strength2 and 6F compatible deliverability4 across the largest size range.3,4

Thin struts with high radial strength

High radial strength

Compared to leading competitor Cobalt Chromium (CoCr)stents up to 23% higher radial strength.2

High stent flexibility is represented by low bending stiffness (Nmm²)

†SST – Stainless Steel

Super flexible stent design

Most flexible stent design compared to leading competitor stents.1

Excellent deliverability

The low profile design with its low crossing profile offers excellent deliverability* compared to leading competitor devices.2,4

*Deliverability = pushability + trackability characteristics

6F compatible in full size range

The thin strut stent design combined with the low profile balloon catheter delivery system offers the full product range in 6F sheath compatibility.4

Prospective, international, multicenter, single-arm study with up to 60-month follow-up evaluating the
safety and efficacy of Dynetic-35 in the treatment of peripheral artery disease in the iliac arteries.

N = 160 subjects

Austria, Belgium,
France, Germany,
Hungary, Latvia

Primary Endpoint:
Major adverse events§ 12 months
post-index procedure

The 12-month BIONETIC-I study results demonstrate safety and effectiveness of iliac treatment with the Dynetic-35 Cobalt Chromium Balloon-Expandable Stent System6:

§Major adverse events includes device or procedure related death within 30 days post index procedure, clinically driven target lesion revascularization,
and major index limb amputation up to 12 months post index procedure.

Physician Testimonials

Flexible stent, flexible access options

The only balloon-expandable cobalt chromium iliac stent system with a 170 cm working
length3 and full 6F compatibility4, enabling a radial access approach and ambulatory treatment.

170 cm Working
length

Benefits of transradial access:

  • Patient comfort7

  • Faster ambulation8

  • Shorter hospitalization9

Principal Investigator of the BIONETIC-TRA study, Dr. Michael Lichtenberg, shares what makes the Dyentic-35 the ideal stent for studying a transradial approach to iliac lesion treatment.

Contact us

  • BIOTRONIK data on file. IIB(P)13-2019. 10.0 mm stent diameter;
  • BIOTRONIK data on file. 8.0 mm stent diameter;
  • Endovascular Today – Europe Buyer´s Guide 2019, Balloon-Expandable Stents. http://evtoday.com/device-guide/european/152#;
  • BIOTRONIK data on file;
  • BIOTRONIK data on file. IIB(P)13-2019. 8.0 mm stent diameter;
  • Brodmann M. Dynetic-35 Balloon-Expandable Stent for peripheral iliac lesions 12m results of the BIONETIC-I multi-center study. Presented at LINC: May 30, Leipzig, Germany.
  • Rutka JK et al. Comparison of patient comfort after coronary angiography by standard arterial access approaches. Kardiol Pol. 2016;74:68-74;
  • Kok MM et al. Patient preference for radial versus femoral vascular access for elective coronary procedures: The PREVAS study. Catheter Cardiovasc Interv. 2018 Jan 1;91(1):17-24;
  • Romagnoli E et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol 2012;60(24):2481–2489.